María Marcela Schmid

Valoración de la calidad del sueño en pacientes con artritis reumatoide, espondiloartritis y lupus eritematoso sistémico: estudio del noreste argentino

Ariana Ringer, Maria Noelia Antoniol, Nora Aste, Emilio Benavente et autres

Introducción: las patologías autoinmunes y sus tratamientos pueden relacionarse con la calidad del sueño. Objetivos: evaluar la calidad del sueño en pacientes con artritis reumatoide (AR), espondiloartritis (SpA) y lupus eritematoso sistémico (LES) a través del cuestionario de Pittsburgh de calidad del …

ar, cu (code pays fourni par la source)

Effectiveness of methotrexate and leflunomide as corticoid-sparing drugs in patients with polymyalgia rheumatica

Juan Pablo Vinicki, Alejandra Cusa, Daniela Domingo, José Luis Velasco Zamora et autres

Abstract Objectives The need for glucocorticoid-sparing drugs (GCSD) remains an important issue and is an unmet need in the treatment of polymyalgia rheumatica (PMR). We therefore aimed to assess the effectiveness and safety of methotrexate (MTX) and of leflunomide (LEF) in daily …

ar, us (code pays fourni par la source)

LSO-023 Clinical characteristics of SARS-CoV-2 infection in patients with systemic lupus erythematosus in Argentina: data from the SAR-COVID national registry

C. A. Isnardi, Karen Roberts, Yohana Tissera, Ingrid Petkovic et autres

Background Patients with systemic lupus erythematosus (SLE) present greater severity of SARS-CoV-2 infection compared to the general population. High disease activity and some immunosuppressants have been associated with worse outcomes. The aim of this study was to describe the characteristics of SARS-CoV-2 …

Compromiso oftálmico en enfermedad relacionada con IgG4

Luisina Victoria Zunino, Romina Calvo, Alejandro Varizat, María Marcela Schmid et autres

Introducción: la enfermedad oftálmica relacionada con IgG4 (EOR-IgG4) presenta una frecuencia del 11-59%. Pocos estudios describen las disparidades con los pacientes con ER-IgG4 extraoftálmica (NO EOR-IgG4). Objetivos: describir las características clínicas, imagenológicas, anatomopatológicas, resultados de laboratorio y tratamiento de la EOR-IgG4, y …

ar (code pays fourni par la source)

Características clínicas y evolución de la infección por SARS-CoV-2 en pacientes con lupus eritematoso sistémico en Argentina: datos del registro nacional SAR-COVID

C. A. Isnardi, Karen Roberts, Yohana Tissera, Ingrid Petkovic et autres

Introducción: el lupus eritematoso sistémico (LES) es una enfermedad sistémica que se ha asociado a mayor severidad con la infección por SARS-CoV-2. Particularmente la alta actividad de la enfermedad y algunos inmunosupresores se han vinculado a peores desenlaces. Objetivos: describir las características …

Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry

C. A. Isnardi, Karen Roberts, Verónica Saurit, Ingrid Petkovic et autres

es, ar, uy, ve (code pays fourni par la source)

Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study

Zara Izadi, Milena Gianfrancesco, Gabriela Schmajuk, Lindsay Jacobsohn et autres

us, de, pt, gb, fr, es, qa, pe, se, it, ar, br, au, ca, nz (code pays fourni par la source)

Temporal trends in COVID-19 outcomes in people with rheumatic diseases in Ireland: data from the COVID-19 Global Rheumatology Alliance registry

Richard Conway, Elena Nikiphorou, Christiana A. Demetriou, Candice Low et autres

OBJECTIVES: Although evidence is accumulating globally, data on outcomes in rheumatic disease and COVID-19 in Ireland are limited. We used data from the COVID-19 Global Rheumatology Alliance (C19-GRA) to describe time-varying COVID-19 outcomes for people with rheumatic disease in Ireland. METHODS: Data …

ie, gb, cy, au, us, nz (code pays fourni par la source)

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

Sebastian E. Sattui, Richard Conway, R C Conway, Michael Putman et autres

BACKGROUND: Patients with primary systemic vasculitis or polymyalgia rheumatica might be at a high risk for poor COVID-19 outcomes due to the treatments used, the potential organ damage cause by primary systemic vasculitis, and the demographic factors associated with these conditions. We …

us, ie, au, gb, ar, br, se, it, fr, de, pt, qa, pe, es, ca, nz (code pays fourni par la source)

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

Zara Izadi, Erica J. Brenner, Satveer K. Mahil, Nick Dand et autres

Importance: Although tumor necrosis factor (TNF) inhibitors are widely prescribed globally because of their ability to ameliorate shared immune pathways across immune-mediated inflammatory diseases (IMIDs), the impact of COVID-19 among individuals with IMIDs who are receiving TNF inhibitors remains insufficiently understood. Objective: …

us, gb, de, es, pt, ch, se, it, qa, ar, br, fr, nz, ca, au (code pays fourni par la source)

Relapsing polychondritis or relapsing polychondritis-like symptoms associated with IgG4-RD. Case reports and review of the literature

Jésica Gallo, María Marcela Schmid, Josefina Gallino Yanzi, Sergio Paira

Relapsing polychondritis (RP) is a rare systemic disorder characterised by recurrent, widespread chondritis of the auricular, nasal, and tracheal cartilages. Immunoglobulin G4-related disease (IgG4-RD) is a systemic immune-mediated disease characterised by the infiltration of IgG4-bearing plasma cells into systemic organs. However, 25-35% …

ar (code pays fourni par la source)

Reply to the Article “Comparing Demographics, Clinical Presentation, Treatment and Outcome Between Sle Patients Treated in One Public and One Private Health System in Santa Fe, Argentina”

María Marcela Schmid, Susana Roverano, Sergio Paira

ar (code pays fourni par la source)